Only one share had a drop of 5% or more, with TAP:Taptica losing 14%. This has almost halved since I bought them, but this drop was caused by the dilution caused by taking over Rhythm One. Immediately after they started a share buy-back scheme and I'm confident it won't be long before they recover. The problem is they are in my trading account which was meant to be for quick wins.
RED:RedT Energy got their placing away successfully and raised the amount required to the strategic review. This is great news and offers some hope. There was also a big grid storage scheme announced for UK. A few more announcements like that and we could be back in the black, just as it was looking like everything was doomed. I got an extra 1,428 shares in the open offer, costing 2p each and a total of £28.56. That dragged down my weighted average price to 9.48p and had the effect of raising the price 5%. They are still down by 79%.
TND:Tandem Group had a couple of big buys, and as there are so few shares in circulation they raised the share price by 7%. These are only 20% down now, so I may be able to get rid of them soon as they would not feature in my portfolio if I came across them now.
BLU:Blue Star Capital are starting to feel a bit more positive about Satoshipay despite the buy-out failing. There still aren't enough publishers using Satoshipay and we really need one of the big newspapers. An 8% rise was welcome, but these are still 74% down.
OPTI:Optibiotix had a good week considering there wasn't really any news. The UK Investor Show may have attracted some interest, which could explain the higher volume and 7p rise which was 11% of purchase price in my ISA but 9% in my SIPP. 7p is worth £5,782, so it's great that £2,354 of this week's improvement came from other shares.
CAML:Central Asia Metals is finally moving. As one of my biggest holdings, the 13% rise was worth a lot. They are now 47% up on my purchase price with paper profit of £2,288. These are a keeper though, as the dividend is immense.
SBTX:SkinBioTherapeutics have been in one of their dip periods, but rocketed up 15% this week. My holding is only 4% down now, so if positive sentiment extends to next week we could easily go into the black.
JLP:Jubilee Metals nearly won Share of the Week with a healthy 16% rise. I was feeling a bit desperate about these, as I had such high hopes but they seemed to keep shooting themselves in the foot. This week Vikrant Bhargava bought 167 million shares which is 9% of the company. Add that to a very positive broker note from Shard Capital with a target price of 6p, and the price climbed by 16%. My holding is still 34% down on purchase price, but this week's rise was worth £700.
Share of the Week is the one I was desperate to get back into when it dropped below 100p, VRS:Versarien. I'm so glad I did as they announced that VRS:Versarien is the first company in the world to become a Verified Graphene Producer by the Graphene Council. This saw the share price climb a whopping 26% so they went from 1% down to 25% up. That's worth £369 paper profit. I'm tempted to trade this share as I think it will be as volatile as OPTI:Optibiotix until they can confirm revenue, but I can't bear to be out as a massive deal could come through at any time. I think for my sanity I will remain a long term investor instead.
Oh happy, happy day, we're back in the black.
Despite the great rise, we're still below the trend line and still dragging it downwards.
The ISA and share portfolios look like this
| Weekly Change | |||
| Cash | £26.97 | -£32.31 | |
| Portfolio cost | £57,274.78 | +£28.56 | |
| Portfolio sell value (bid price - commission) | £55,755.33 | (-2.7%) | +£4,785.13 |
| Potential profits | £9,371.24 | +£3,569.87 | |
| Yr 4 Dividends | £60.50 | +£0 | |
| Yr 4 Profit from sales | £1,077.60 | +£0 | |
| Yr 4 Average monthly cash profit | £137.19 | (2.9%) | -£4.52 |
| Total Dividends | £1,298.83 | +£0 | |
| Total Profit from sales | £19,774.72 | +£0 | |
| Average monthly cash profit | £474.10 | (9.9%) | -£2.58 |
| (Sold stocks profit + Dividends - Fees / Months) |
Cash dropped due to the RED:RedT Energy open offer and monthly ISA fee. Paper profit up £3,569 but absolutely brilliant news that losses were reduced by £1,200 as it's the losing shares that are dragging down the performance. Average monthly performance dropped below the target 10% for the first time in ages, but the only company in profit other than OPTI:Optibiotix is CWR:Ceres Power and I want to hold those long term.
Main targets for selling are TND:Tandem Group but that would likely be accepting a loss to free up funds, SBTX:SkinBioTherapeutics which I may trade as they are so volatile, and IKA:Ilika which could be ok but I don't like companies where the directors are more interested in doing science than making money for shareholders.
Still under water but not by much
The trend line is almost flat and right along the £0 line. We're still below the trend line so it may be flat by next week.
The SIPP looks like this after week 175
| Weekly Change | |||
| Cash | £78.66 | -£14.41 | |
| Portfolio cost | £40,524.05 | +£2,199.28 | |
| Portfolio sell value (bid price - commission) | £44,413.24 | (9.6%) | +£3,358.30 |
| Potential profits | £8,175.77 | +£3,261.31 | |
| Yr 4 Dividends | £0 | +£0 | |
| Yr 4 Interest | £0.05 | +£0 | |
| Yr 4 Profit from sales | £484.30 | +£0 | |
| Yr 4 Average monthly cash profit | £96.59 | (2.9%) | -£9.01 |
| Total Dividends | £1,342.25 | +£0 | |
| Total Interest | £0.08 | +£0 | |
| Total Profit from sales | £11,029.22 | +£0 | |
| Average monthly cash profit | £297.85 | (8.8%) | -£2.09 |
| (Sold stocks profit + Dividends - Fees / Months) |
Cash dropped due to monthly fees, and cost went up as I invested my pension transfer in more OPTI:Optibiotix shares. Potential profits were up loads, and losses were reduced by almost £100. The increase in portfolio cost hammered the average performance percentage, dropping from 9.9% to 8.8% and a long way off the target 10%. I just need a bit of a gold rally so I can sell PAF:Pan African Resources to get the performance figure back up. I really need some good news form MMX:Minds+Machines as I'd quite like to be able to sell those, but they are 28% down.
Zoom!
Back above the trend line. Let's start dragging it upwards!
The trading account looks like this after week 141
| Weekly Change | |||
| Cash | £18.80 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,490.86 | (-35.8%) | -£6.63 |
| Potential profits | £25.17 | +£25.17 | |
| Year 3 Dividends | £17.33 | +£0 | |
| Year 3 Profit | £177.06 | +£0 | |
| Yr 3 Average monthly cash profit | £22.77 | (11.8%) | -£0.63 |
| Dividends | £18.48 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£1.41 | (-0.7%) | +£0.01 |
| (Sold stocks profit + Dividends - Fees / Months) |
Great week for CAML:Central Asia Metals taking potential profit to £25. I need at least £65 if I'm going to get back to long term break-even. Pretty pathetic really to still be at a loss after nearly 3 years. I'm not very good at trading because I don't know how to take a quick loss. TAP:Taptica ruined the week by dropping so much that the gains elsewhere were turned into an overall £6 loss.
Still pretty dreadful.
Very slowly flattening the trend line, but if it flattens it will be well below £0.
I popped onto the NEX website and discovered BLOC:Block Commodities are no longer suspended. It allowed them to drop even further to 0.01p. I guess the fact they are still in existence means there's a fragment of hope I may get some of my £700 back, but I suspect it's a fools hope.
This week has restored my wavering faith, as the relentless gloom was getting a bit depressing. There's no doubt some of my riskier investments are doomed, but they are all fighting on, so maybe a few will come good.
No comments:
Post a Comment